Cargando…
Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage
This study explores the effect of physical aging and/or crystallization on the supersaturation potential and crystallization kinetics of amorphous active pharmaceutical ingredients (APIs). Spray-dried, fully amorphous indapamide, metolazone, glibenclamide, hydrocortisone, hydrochlorothiazide, ketoco...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696415/ https://www.ncbi.nlm.nih.gov/pubmed/31357587 http://dx.doi.org/10.3390/molecules24152731 |
_version_ | 1783444265131573248 |
---|---|
author | Edueng, Khadijah Mahlin, Denny Gråsjö, Johan Nylander, Olivia Thakrani, Manish Bergström, Christel A.S. |
author_facet | Edueng, Khadijah Mahlin, Denny Gråsjö, Johan Nylander, Olivia Thakrani, Manish Bergström, Christel A.S. |
author_sort | Edueng, Khadijah |
collection | PubMed |
description | This study explores the effect of physical aging and/or crystallization on the supersaturation potential and crystallization kinetics of amorphous active pharmaceutical ingredients (APIs). Spray-dried, fully amorphous indapamide, metolazone, glibenclamide, hydrocortisone, hydrochlorothiazide, ketoconazole, and sulfathiazole were used as model APIs. The parameters used to assess the supersaturation potential and crystallization kinetics were the maximum supersaturation concentration (C(max,app)), the area under the curve (AUC), and the crystallization rate constant (k). These were compared for freshly spray-dried and aged/crystallized samples. Aged samples were stored at 75% relative humidity for 168 days (6 months) or until they were completely crystallized, whichever came first. The solid-state changes were monitored with differential scanning calorimetry, Raman spectroscopy, and powder X-ray diffraction. Supersaturation potential and crystallization kinetics were investigated using a tenfold supersaturation ratio compared to the thermodynamic solubility using the µDISS Profiler. The physically aged indapamide and metolazone and the minimally crystallized glibenclamide and hydrocortisone did not show significant differences in their C(max,app) and AUC when compared to the freshly spray-dried samples. Ketoconazole, with a crystalline content of 23%, reduced its C(max,app) and AUC by 50%, with C(max,app) being the same as the crystalline solubility. The AUC of aged metolazone, one of the two compounds that remained completely amorphous after storage, significantly improved as the crystallization kinetics significantly decreased. Glibenclamide improved the most in its supersaturation potential from amorphization. The study also revealed that, besides solid-state crystallization during storage, crystallization during dissolution and its corresponding pathway may significantly compromise the supersaturation potential of fully amorphous APIs. |
format | Online Article Text |
id | pubmed-6696415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66964152019-09-05 Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage Edueng, Khadijah Mahlin, Denny Gråsjö, Johan Nylander, Olivia Thakrani, Manish Bergström, Christel A.S. Molecules Article This study explores the effect of physical aging and/or crystallization on the supersaturation potential and crystallization kinetics of amorphous active pharmaceutical ingredients (APIs). Spray-dried, fully amorphous indapamide, metolazone, glibenclamide, hydrocortisone, hydrochlorothiazide, ketoconazole, and sulfathiazole were used as model APIs. The parameters used to assess the supersaturation potential and crystallization kinetics were the maximum supersaturation concentration (C(max,app)), the area under the curve (AUC), and the crystallization rate constant (k). These were compared for freshly spray-dried and aged/crystallized samples. Aged samples were stored at 75% relative humidity for 168 days (6 months) or until they were completely crystallized, whichever came first. The solid-state changes were monitored with differential scanning calorimetry, Raman spectroscopy, and powder X-ray diffraction. Supersaturation potential and crystallization kinetics were investigated using a tenfold supersaturation ratio compared to the thermodynamic solubility using the µDISS Profiler. The physically aged indapamide and metolazone and the minimally crystallized glibenclamide and hydrocortisone did not show significant differences in their C(max,app) and AUC when compared to the freshly spray-dried samples. Ketoconazole, with a crystalline content of 23%, reduced its C(max,app) and AUC by 50%, with C(max,app) being the same as the crystalline solubility. The AUC of aged metolazone, one of the two compounds that remained completely amorphous after storage, significantly improved as the crystallization kinetics significantly decreased. Glibenclamide improved the most in its supersaturation potential from amorphization. The study also revealed that, besides solid-state crystallization during storage, crystallization during dissolution and its corresponding pathway may significantly compromise the supersaturation potential of fully amorphous APIs. MDPI 2019-07-27 /pmc/articles/PMC6696415/ /pubmed/31357587 http://dx.doi.org/10.3390/molecules24152731 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Edueng, Khadijah Mahlin, Denny Gråsjö, Johan Nylander, Olivia Thakrani, Manish Bergström, Christel A.S. Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage |
title | Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage |
title_full | Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage |
title_fullStr | Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage |
title_full_unstemmed | Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage |
title_short | Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage |
title_sort | supersaturation potential of amorphous active pharmaceutical ingredients after long-term storage |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696415/ https://www.ncbi.nlm.nih.gov/pubmed/31357587 http://dx.doi.org/10.3390/molecules24152731 |
work_keys_str_mv | AT eduengkhadijah supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage AT mahlindenny supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage AT grasjojohan supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage AT nylanderolivia supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage AT thakranimanish supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage AT bergstromchristelas supersaturationpotentialofamorphousactivepharmaceuticalingredientsafterlongtermstorage |